We are live on ! Find out more
CARL

Carlsmed

57 hedge funds and large institutions have $57.7M invested in Carlsmed in 2025 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 7

122% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 9

19% more funds holding

Funds holding: 4857 (+9)

0.04% more ownership

Funds ownership: 17.53%17.58% (+0.04%)

8% less capital invested

Capital invested by funds: $62.4M → $57.7M (-$4.68M)

Holders
57
Holders Change
+9
Holders Change %
+18.75%
% of All Funds
0.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
20
Reduced
9
Closed
7
Calls
Puts
Net Calls
Net Calls Change

CARL Hedge Fund Activity: Q4 2025 in Review

57 of the 8,229 institutional investors tracked by Wall St. Rank reported a position in Carlsmed (CARL) for Q4 2025, worth a combined $57.7M — down 7.5% from $62.4M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new CARL positions and 7 closed out — a net gain of 9 holders — while 20 added to existing stakes and 9 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.77M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $4.31M sold.

  • 57 institutional investors held Carlsmed (CARL) as of Q4 2025, up from 48 in Q3 2025.
  • Funds reported $57.7M of Carlsmed stock for Q4 2025, down 7.5% quarter-over-quarter.
  • 16 funds opened new Carlsmed positions in Q4 2025 and 7 closed out, a net change of +9 holders.
  • The largest Carlsmed buyer in Q4 2025 was Vanguard Group, an estimated $1.77M added.
  • The largest Carlsmed seller in Q4 2025 was Avidity Partners Management, an estimated $4.31M sold.

Based on aggregated 13F filings for Q4 2025.